{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:33:48Z","timestamp":1793036028446,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009093","name":"Scuola Normale Superiore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AlfaSigma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In patients with Parkinson\u2019s disease (PD), constipation is common, and it appears in a prodromal stage before the hallmark motor symptoms. The present study aimed to investigate whether Velusetrag, a selective 5\u2011HT4 receptor agonist, may be a suitable candidate to improve intestinal motility in a mouse model of PD. Five months old PrP human A53T alpha-synuclein transgenic (Tg) mice, which display severe constipation along with decreased colonic cholinergic transmission already at 3 months, were treated daily with the drug for 4 weeks. Velusetrag treatment reduced constipation by significantly stimulating both the longitudinal and circular-driven contractions and improved inflammation by reducing the level of serum and colonic IL1\u03b2 and TNF-\u03b1 and by decreasing the number of GFAP-positive glia cells in the colon of treated mice. No significant downregulation of the 5-HT4 receptor was observed but instead Velusetrag seemed to improve axonal degeneration in Tgs as shown by an increase in NF-H and VAChT staining. Ultimately, Velusetrag restored a well-balanced intestinal microbial composition comparable to non-Tg mice. Based on these promising data, we are confident that Velusetrag is potentially eligible for clinical studies to treat constipation in PD patients.<\/jats:p>","DOI":"10.1038\/s41531-023-00582-1","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:01:41Z","timestamp":1696204901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Jessica","family":"Grigoletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7103-668X","authenticated-orcid":false,"given":"Fabiana","family":"Miraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-5430","authenticated-orcid":false,"given":"Carolina","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Soldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Merlo","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-7450","authenticated-orcid":false,"given":"Emanuela","family":"Colla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0110-0106","authenticated-orcid":false,"given":"Loredana","family":"Vesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Ross, J. & Spillantini, M. G. The synucleinopathies: twenty years on. J. Parkinsons Dis. 7, S51\u2013S69 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"582_CR2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng, H.-C., Ulane, C. M. & Burke, R. E. Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 67, 715\u2013725 (2010).","journal-title":"Ann. Neurol."},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"582_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JPD-161050","volume":"7","author":"K Knudsen","year":"2017","unstructured":"Knudsen, K. et al. Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson\u2019s disease: a colon transit and volume study. J. Parkinsons Dis. 7, 359\u2013367 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"582_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JPD-171131","volume":"7","author":"K Knudsen","year":"2017","unstructured":"Knudsen, K. et al. Gastrointestinal transit time in parkinson\u2019s disease using a magnetic tracking system. J. Parkinsons Dis. 7, 471\u2013479 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"582_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/bs.irn.2017.06.003","volume":"134","author":"F Stocchi","year":"2017","unstructured":"Stocchi, F. & Torti, M. Constipation in Parkinson\u2019s disease. Int Rev. Neurobiol. 134, 811\u2013826 (2017).","journal-title":"Int Rev. Neurobiol."},{"key":"582_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach, T. G. et al. Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119, 689\u2013702 (2010).","journal-title":"Acta Neuropathol."},{"key":"582_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2012.07.018","volume":"48","author":"M B\u00f6ttner","year":"2012","unstructured":"B\u00f6ttner, M. et al. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol 48, 474\u2013480 (2012).","journal-title":"Neurobiol"},{"key":"582_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/nan.12486","volume":"44","author":"C Ruffmann","year":"2018","unstructured":"Ruffmann, C. et al. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson\u2019s disease. Neuropathol. Appl Neurobiol. 44, 722\u2013736 (2018).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"582_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0408-2","volume":"5","author":"M Barrenschee","year":"2017","unstructured":"Barrenschee, M. et al. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson\u2019s disease. Acta Neuropathol. Commun. 5, 1 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"582_CR11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cell.2020.08.003","volume":"182","author":"E Drokhlyansky","year":"2020","unstructured":"Drokhlyansky, E. et al. The human and mouse enteric nervous system at single-cell resolution. Cell 182, 1606\u20131622 (2020).","journal-title":"Cell"},{"key":"582_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41593-020-00736-x","volume":"24","author":"K Morarach","year":"2021","unstructured":"Morarach, K. et al. Diversification of molecularly defined myenteric neuron classes revealed by single-cell RNA sequencing. Nat. Neurosci. 24, 34\u201346 (2021).","journal-title":"Nat. Neurosci."},{"key":"582_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41531-022-00308-9","volume":"8","author":"A Chalazonitis","year":"2022","unstructured":"Chalazonitis, A., Rao, M. & Sulzer, D. Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 50 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen, K. et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 17, 618\u2013628 (2018).","journal-title":"Lancet Neurol."},{"key":"582_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","volume":"88","author":"TD Fedorova","year":"2017","unstructured":"Fedorova, T. D. et al. Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study. Neurology 88, 775\u2013781 (2017).","journal-title":"Neurology"},{"key":"582_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13105-017-0566-0","volume":"73","author":"M Auteri","year":"2016","unstructured":"Auteri, M., Zizzo, M. G., Amato, A. & Serio, R. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. J. Physiol. Biochem. 73, 395\u2013404 (2016).","journal-title":"J. Physiol. Biochem."},{"key":"582_CR17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.phrs.2018.06.017","volume":"140","author":"DJ Keating","year":"2019","unstructured":"Keating, D. J. & Spencer, N. J. What is the role of endogenous gut serotonin in the control of gastrointestinal motility? Pharmacol. Res. 140, 50\u201355 (2019).","journal-title":"Pharmacol. Res."},{"key":"582_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","volume":"10","author":"GM Mawe","year":"2013","unstructured":"Mawe, G. M. & Hoffman, J. M. Serotonin signalling in the gut\u2013functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10, 473\u2013486 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2982.2002.00325.x","volume":"14","author":"RL Monro","year":"2002","unstructured":"Monro, R. L., Bertrand, P. P. & Bornstein, J. C. ATP and 5-HT are the principal neurotransmitters in the descending excitatory reflex pathway of the guinea-pig ileum. Neurogastroenterol. Motil. 14, 255\u2013264 (2002).","journal-title":"Neurogastroenterol. Motil."},{"key":"582_CR20","doi-asserted-by":"crossref","first-page":"G1148","DOI":"10.1152\/ajpgi.00245.2005","volume":"289","author":"M Liu","year":"2005","unstructured":"Liu, M., Geddis, M. S., Wen, Y., Setlik, W. & Gershon, M. D. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1148\u2013G1163 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"582_CR21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.gastro.2011.12.041","volume":"142","author":"JM Hoffman","year":"2012","unstructured":"Hoffman, J. M. et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 142, 844\u2013854 (2012).","journal-title":"Gastroenterology"},{"key":"582_CR22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1365-2036.2010.04456.x","volume":"32","author":"M Goldberg","year":"2010","unstructured":"Goldberg, M. et al. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation \u2013 a 4-week, randomized, double-blind, placebo-controlled, dose\u2013response study. Aliment. Pharmacol. Ther. 32, 1102\u20131112 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/apt.16344","volume":"53","author":"B Kuo","year":"2021","unstructured":"Kuo, B. et al. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study. Aliment. Pharm. Ther. 53, 1090\u20131097 (2021).","journal-title":"Aliment. Pharm. Ther."},{"key":"582_CR24","doi-asserted-by":"crossref","first-page":"e14523","DOI":"10.1111\/nmo.14523","volume":"35","author":"TL Abell","year":"2023","unstructured":"Abell, T. L. et al. Arandomized, double-blind, placebo-controlled, phase 2b studyof the efficacy and safety of velusetrag in subjects withdiabetic or idiopathic gastroparesis. Neurogastroenterol. Motil. 35, e14523 (2023).","journal-title":"Neurogastroenterol. Motil."},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2011.02.026","volume":"61","author":"F Shen","year":"2011","unstructured":"Shen, F. et al. 5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: a pharmacodynamic and pharmacokinetic assessment. Neuropharm 61, 69\u201379 (2011).","journal-title":"Neuropharm"},{"key":"582_CR26","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.3390\/ijms20215340","volume":"20","author":"T Ishii","year":"2019","unstructured":"Ishii, T., Kinoshita, K. I. & Muroi, Y. Serotonin 5-HT4 receptor agonists improve facilitation of contextual fear extinction in an MPTP-induced mouse model of Parkinson\u2019s disease. Int. J. Mol. Sci. 20, 5340 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"582_CR27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","volume":"8","author":"L Rota","year":"2019","unstructured":"Rota, L. et al. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alphasynucleinopathy. Transl. Neurodegener. 8, 5 (2019).","journal-title":"Transl. Neurodegener."},{"key":"582_CR28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2982.2010.01474.x","volume":"22","author":"H Matsuyoshi","year":"2010","unstructured":"Matsuyoshi, H. et al. A 5-HT4-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult. Neurogastroenterol. Motil. 22, 806\u2013e226 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"582_CR29","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.2174\/1381612825666191210154535","volume":"25","author":"Y Lee","year":"2020","unstructured":"Lee, Y., Lee, B. H., Yip, W., Chou, P. & Yip, B. S. Neurofilament proteins as prognostic biomarkers in neurological disorders. Curr. Pharm. Des. 25, 4560\u20134569 (2020).","journal-title":"Curr. Pharm. Des."},{"key":"582_CR30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neures.2003.11.008","volume":"48","author":"M Maeda","year":"2004","unstructured":"Maeda, M. et al. Vesicular acetylcholine transporter can be a morphological marker for the reinnervation to muscle of regenerating motor axons. Neurosci. Res. 48, 305\u2013314 (2004).","journal-title":"Neurosci. Res."},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuroscience.2019.10.029","volume":"423","author":"M Swaminathan","year":"2019","unstructured":"Swaminathan, M., Fung, C., Finkelstein, D. I., Bornstein, J. C. & Foong, J. P. P. \u03b1-synuclein regulates development and function of cholinergic enteric neurons in the mouse colon. Neurosci 423, 76\u201385 (2019).","journal-title":"Neurosci"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/MCB.01665-08","volume":"29","author":"HA Acosta-Jaquez","year":"2009","unstructured":"Acosta-Jaquez, H. A. et al. Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth. Mol. Cell Biol. 29, 4308\u20134324 (2009).","journal-title":"Mol. Cell Biol."},{"key":"582_CR33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","volume":"8","author":"TF Jiang","year":"2013","unstructured":"Jiang, T. F. et al. Curcumin ameliorates the neurodegenerative pathology in A53T \u03b1-synuclein cell model of Parkinson\u2019s disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy. J. Neuroimmune Pharm. 8, 356\u2013369 (2013).","journal-title":"J. Neuroimmune Pharm."},{"key":"582_CR34","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00364-w","volume":"15","author":"MR Karim","year":"2020","unstructured":"Karim, M. R. et al. \u03b1-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment. Mol. Neurodegeneration 15, 27 (2020).","journal-title":"Mol. Neurodegeneration"},{"key":"582_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini, C. et al. Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Parkinsons Dis. 8, 9 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"582_CR36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"582_CR37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3892\/mmr.2021.12374","volume":"24","author":"Q Lei","year":"2021","unstructured":"Lei, Q. et al. Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson\u2019s disease progression (Review). Mol. Med. Rep. 24, 734 (2021).","journal-title":"Mol. Med. Rep."},{"key":"582_CR38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1871523018666190911121306","volume":"19","author":"VN Madia","year":"2020","unstructured":"Madia, V. N. et al. Tegaserod for the treatment of irritable bowel syndrome. Antiinflamm. Antiallergy Agents Med. Chem. 19, 342\u2013369 (2020).","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"582_CR39","doi-asserted-by":"crossref","first-page":"e13302","DOI":"10.1111\/nmo.13302","volume":"30","author":"JR Giudicessi","year":"2018","unstructured":"Giudicessi, J. R., Ackerman, M. J. & Camilleri, M. Cardiovascular safety of prokinetic agents: a focus on drug-induced arrhythmias. Neurogastroenterol. Motil. 30, e13302 (2018).","journal-title":"Neurogastroenterol. Motil."},{"key":"582_CR40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/17474124.2019.1568238","volume":"13","author":"G Bassotti","year":"2019","unstructured":"Bassotti, G., Usai Satta, P. & Bellini, M. Prucalopride for the treatment of constipation: a view from 2015 and beyond. Expert Rev. Gastroenterol. Hepatol. 13, 257\u2013262 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"582_CR41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s40264-019-00835-0","volume":"42","author":"A Gilsenan","year":"2019","unstructured":"Gilsenan, A. et al. Cardiovascular safety of prucalopride in patients with chronic constipation: a multinational population-based cohort study. Drug Saf. 42, 1179\u20131190 (2019).","journal-title":"Drug Saf."},{"key":"582_CR42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00702-021-02445-6","volume":"129","author":"P Derkinderen","year":"2022","unstructured":"Derkinderen, P. et al. Gastrointestinal mucosal biopsies in Parkinson\u2019s disease: beyond alpha-synuclein detection. J. Neural Transm. (Vienna) 129, 1095\u20131103 (2022).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"582_CR43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1523\/JNEUROSCI.3982-03.2004","volume":"24","author":"ZS Li","year":"2004","unstructured":"Li, Z. S., Pham, T. D., Tamir, H., Chen, J. J. & Gershon, M. D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J. Neurosci. 24, 1330\u20131339 (2004).","journal-title":"J. Neurosci."},{"key":"582_CR44","first-page":"13968","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee, M. K. et al. Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 \u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. 99, 13968\u201318973 (2002).","journal-title":"Proc. Natl Acad. Sci."},{"key":"582_CR45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","volume":"21","author":"EL Unger","year":"2006","unstructured":"Unger, E. L. et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol. Dis. 21, 431\u2013443 (2006).","journal-title":"Neurobiol. Dis."},{"key":"582_CR46","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","volume":"26","author":"ZS Li","year":"2006","unstructured":"Li, Z. S., Schmauss, C., Cuenca, A., Ratcliffe, E. & Gershon, M. D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci. 26, 2798\u20132807 (2006).","journal-title":"J. Neurosci."},{"key":"582_CR47","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2018-317263","volume":"68","author":"N Stakenborg","year":"2019","unstructured":"Stakenborg, N. et al. Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons. Gut 68, 1406\u20131416 (2019).","journal-title":"Gut"},{"key":"582_CR48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho, V. T. E. et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol. Neurodegener. 16, 6 (2021).","journal-title":"Mol. Neurodegener."},{"key":"582_CR49","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.3233\/JPD-191711","volume":"9","author":"JM Boertien","year":"2019","unstructured":"Boertien, J. M., Pereira, P. A. B., Aho, V. T. E. & Scheperjans, F. Increasing comparability and utility of gut microbiome studies in parkinson\u2019s disease: a systematic review. J. Parkinsons Dis. 9, S297\u2013S312 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"582_CR50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41531-022-00300-3","volume":"8","author":"PAB Pereira","year":"2022","unstructured":"Pereira, P. A. B. et al. Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 39 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"582_CR51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm, N. W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000\u20131010 (2014).","journal-title":"Cell"},{"key":"582_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 7, 27 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"582_CR53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30, 350\u2013358 (2015).","journal-title":"Mov. Disord."},{"key":"582_CR54","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian, A. et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov. Disord. 30, 1351\u20131360 (2015).","journal-title":"Mov. Disord."},{"key":"582_CR55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"582_CR56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ijbiomac.2020.07.180","volume":"164","author":"XL Dong","year":"2020","unstructured":"Dong, X. L. et al. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson\u2019s disease model. Int. J. Biol. Macromol. 164, 994\u20131005 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"582_CR57","doi-asserted-by":"crossref","first-page":"e0119121","DOI":"10.1128\/msystems.01191-21","volume":"7","author":"SP van Kessel","year":"2022","unstructured":"van Kessel, S. P., Bullock, A., van Dijk, G. & El Aidy, S. Parkinson\u2019s disease medication alters small intestinal motility and microbiota composition in healthy rats. mSystems 7, e0119121 (2022).","journal-title":"mSystems"},{"key":"582_CR58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3389\/fnins.2019.01184","volume":"13","author":"M Jin","year":"2019","unstructured":"Jin, M. et al. Analysis of the gut microflora in patients with Parkinson\u2019s disease. Front Neurosci. 13, 1184 (2019).","journal-title":"Front Neurosci."},{"key":"582_CR59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ejhg.2008.21","volume":"16","author":"S Girirajan","year":"2008","unstructured":"Girirajan, S. et al. How much is too much? Phenotypic consequences of Rai1 overexpression in mice. Eur. J. Hum. Genet. 16, 941\u2013954 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"582_CR60","doi-asserted-by":"publisher","unstructured":"Wertman, V., Gromova, A., La Spada, A. R., Cortes, C. J. Low-cost gait analysis for behavioral phenotyping of mouse models of neuromuscular disease. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59878 (2019).","DOI":"10.3791\/59878"},{"key":"582_CR61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11302-017-9577-0","volume":"13","author":"L Antonioli","year":"2017","unstructured":"Antonioli, L. et al. Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2Badenosine receptors. Purinergic Signal. 13, 497\u2013510 (2017).","journal-title":"Purinergic Signal."},{"key":"582_CR62","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.115.228510","volume":"356","author":"M Fornai","year":"2016","unstructured":"Fornai, M. et al. Enteric dysfunctions in experimental parkinson\u2019s disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats. J. Pharm. Exp. Ther. 356, 434\u2013444 (2016).","journal-title":"J. Pharm. Exp. Ther."},{"key":"582_CR63","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla, E. et al. Endoplasmic reticulum stress is important for the manifestations of \u03b1-synucleinopathy in vivo. J. Neurosci. 32, 3306\u20133320 (2012).","journal-title":"J. Neurosci."},{"key":"582_CR64","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-021-00439-2","volume":"16","author":"M Gries","year":"2021","unstructured":"Gries, M. et al. Parkinson mice show functional and molecular changes in the gut long before motoric disease onset. Mol. Neurodegener. 16, 34 (2021).","journal-title":"Mol. Neurodegener."},{"key":"582_CR65","first-page":"100916","volume":"25","author":"MH Shihan","year":"2021","unstructured":"Shihan, M. H., Novo, S. G., Le Marchand, S. J., Wang, Y. & Duncan, M. K. A simple method for quantitating confocal fluorescent images. Biochem. Biophys. Rep. 25, 100916 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"582_CR66","first-page":"e00009","volume":"1","author":"W Walters","year":"2015","unstructured":"Walters, W. et al. Improved bacterial 16S rRNA gene (V4 and V4-5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. ASM J. \/ mSystems 1, e00009\u2013e00015 (2015).","journal-title":"ASM J. \/ mSystems"},{"key":"582_CR67","first-page":"e00127","volume":"2","author":"AM Comeau","year":"2017","unstructured":"Comeau, A. M., Douglas, G. M. & Langille, M. G. Microbiome helper: a custom and streamlined workflow for microbiome research. ASM J. \/ mSystems 2, e00127\u201316 (2017).","journal-title":"ASM J. \/ mSystems"},{"key":"582_CR68","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"582_CR69","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Mago\u010d","year":"2011","unstructured":"Mago\u010d, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957\u20132963 (2011).","journal-title":"Bioinformatics"},{"key":"582_CR70","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol 75, 7537\u20137541 (2009).","journal-title":"Appl. Environ. Microbiol"},{"key":"582_CR71","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194\u20132200 (2011).","journal-title":"Bioinformatics"},{"key":"582_CR72","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ. Microbiol. 73, 5261\u20135267 (2007).","journal-title":"Appl Environ. Microbiol."},{"key":"582_CR73","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998 (2013).","journal-title":"Nat. Methods"},{"key":"582_CR74","first-page":"1","volume":"67","author":"E Marcon","year":"2015","unstructured":"Marcon, E. & H\u00e9rault, B. Entropart: an R package to measure and partition diversity. J. Stat. Softw. 67, 1\u201326 (2015).","journal-title":"J. Stat. Softw."},{"key":"582_CR75","first-page":"5","volume":"2","author":"J Oksanen","year":"2019","unstructured":"Oksanen, J. et al. Vegan: community ecology package. R. package version 2, 5\u20136 (2019).","journal-title":"R. package version"},{"key":"582_CR76","unstructured":"R Core Team (2018) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. (2018)."},{"key":"582_CR77","unstructured":"Mendiburu, F. (2020) Agricolae. R Package Version 1.3-3, statistical procedures for agricultural research. R Foundation for Statistical Computing, Vienna (2020)."},{"key":"582_CR78","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-017-0237-y","volume":"5","author":"S Weiss","year":"2017","unstructured":"Weiss, S. et al. Normalization and microbial differential abundance strategies depend upon data characteristics. Microbiome 5, 27 (2017).","journal-title":"Microbiome"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00582-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T17:07:24Z","timestamp":1700500044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00582-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00582-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2625763\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}